13-CIS-RETINOIC ACID AND BONE-DENSITY

被引:19
作者
KOCIJANCIC, M
机构
[1] Department of Dermatology, University Medical Centre Ljubljana, Ljubljana
关键词
D O I
10.1111/j.1365-4362.1995.tb04666.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. 13-Cis-retinoic acid has an influence on bone in patients on long-term treatment as well as on short-term treatment. The presence of skeletal abnormalities after the treatment was established by roentgenologic and scintigraphic examinations. We wanted to know whether a B-month course of low-dose 13-cis-retinoic acid has a clinically important influence on bone density in men with severe acne. Methods. We examined 15 men with severe acne before and after treatment with 13-cis-retinoic acid by dual-photon absorptiometry of the lumbar spine. Results. The mean increase in bone density was 3.0% (95% confidence interval 1.3-4.5), which is normal for the period from puberty to late twenties. Bone density increased in 13 of our 15 patients. Conclusions. As shown by this highly sensitive modern densitometric method, 13-cis-retinoic acid has no clinically important influence on bone density in male patients with severe acne.
引用
收藏
页码:733 / 734
页数:2
相关论文
共 9 条
[1]  
CAREY BM, 1988, BRIT J DERMATOL, V109, P609
[2]  
JEVTIC V, 1989, OSTEOPOROZA, P42
[3]   THE SPECTRUM OF SKELETAL CHANGES ASSOCIATED WITH LONG-TERM ADMINISTRATION OF 13-CIS-RETINOIC ACID [J].
LAWSON, JP ;
MCGUIRE, J .
SKELETAL RADIOLOGY, 1987, 16 (02) :91-97
[4]  
MATKOVIC V, 1991, NUTR TODAY MAR, P21
[5]   THE DEFINITION AND DIAGNOSIS OF OSTEOPOROSIS [J].
NORDIN, BEC .
CALCIFIED TISSUE INTERNATIONAL, 1987, 40 (02) :57-58
[6]  
OTT SM, J CLIN ENDOCR METAB, V71, pA1082
[7]  
SALOBIR B, 1989, OSTEOPOROZA, P33
[8]  
TOROK I, 1988, BRIT J DERMATOL, V120, P31
[9]  
ZELGER B, 1990, HAUTARZT, V41, P537